Competent advice inDrug advertising law
Do you need help in advertising drugs?
- Review of online advertising
- Inspection of catalogue advertising
- Bonuses / Discounts
- price advertising
- remote treatments
- mandatory information
- Warning / Legal proceedings
We are pleased to assist!
If you have any questions regarding german drug advertising law, please contact us by email at
Of course you can also reach us by phone at +49 (40) 33443690.
Unlike normal consumer goods, medicines and other medicinal products are not harmless products. Whether it be in the prescription or over-the-counter sector, contra-indications, reciprocal effects, side effects or incorrect dosage can lead to health risks. Advertising that essentially aims at encouraging use of a certain product may be at odds with these risks. Medicinal product advertising law is intended to protect the consumer from impermissible advertising. We will support you in this complex matter and help you to bring your interests and goals into harmony with provisions under medicinal product advertising law.
Our role includes the following:
- Delimitation of product and company advertising
- Obligatory informationInformation on bans
- Advertising in the package insert and labelling
- Inspection of all kinds of advertising
- Donations, give-aways and other promotional gifts as well as permissible exceptions
- Advice in the creation of advertising campaigns for pharmacies and doctors' practices
- Explanation of obligatory information in medicine advertising
- Reviewing the legality of clinic advertising
PharmSec Internattional GmbH, founded in cooperation with the law firm DIEKMANN Rechtsanwälte, advises companies in particular in the areas of medicinal products and narcotics (BtM) and supports them in applying for and maintaining permits (e.g. for wholesale trade in medicinal products pursuant to § 52a of the German Medicinal Products Act (AMG) or for trade in narcotics pursuant to § 3 of the German Narcotics Act (BtMG)).
The brains behind the company are, in addition to Dr. Fabinne Diekmann, Mr. Stefan Heinz, who has many years of experience in QA/GMP/GDP - most recently as head of quality assurance at Mundipharma GmbH in Limburg (Lahn). In addition, he has many years of experience in conducting quality audits (3rd party audits) and inspections by authorities in the national and international environment.
In addition, PharmSec offers its own training courses and acts as a speaker on various platforms.